Critical transition and reversion of tumorigenesis

참고문헌 (78)

1. Kenny, P. A., "Tumor reversion: correction of malignant behavior by microenvironmental cues", Int. J. Cancer, 107, pp.688~695 (2003)
2. Askanazy, M., "Die Teratome nach ihrem Bau, ihrem Verlauf, ihrer Genese und im Vergleich zum experimentellen Teratoid", Verhandl. Dtsch. Pathol. Gesellsch, 11, pp.44~ (1907)
3. Cho, K. -H., "Cancer reversion, a renewed challenge in systems biology", Curr. Opin. Syst. Biol, 2, pp.49~58 (2017)
4. Mintz, B., "Normal genetically mosaic mice produced from malignant teratocarcinoma cells", Proc. Natl Acad. Sci. USA, 72, pp.3585~3589 (1975)
5. Lo-Coco, F., "Targeted therapy alone for acute promyelocytic leukemia", N. Engl. J. Med, 374, pp.1197~1198 (2016)
6. Cicconi, L., "PML-RARalpha kinetics and impact of FLT3-ITD mutations in newly diagnosed acute promyelocytic leukaemia treated with ATRA and ATO or ATRA and chemotherapy", Leukemia, 30, pp.1987~1992 (2016)
7. Burnett, A. K., "Arsenic trioxide and all-trans retinoic acid treatment for acute promyelocytic leukaemia in all risk groups(AML17) : results of a randomised, controlled, phase 3 trial", Lancet Oncol, 16, pp.1295~1305 (2015)
8. Lo-Coco, F., "Retinoic acid and arsenic trioxide for acute promyelocytic leukemia", N. Engl. J. Med, 369, pp.111~121 (2013)
9. Dow, L. E., "Apc restoration promotes cellular differentiation and reestablishes crypt homeostasis in colorectal cancer", Cell, 161, pp.1539~1552 (2015)
10. Telerman, A., "The molecular programme of tumour reversion : the steps beyond malignant transformation", Nat. Rev. Cancer, 9, pp.206~216 (2009)
11. Tuynder, M., "Biological models and genes of tumor reversion : cellular reprogramming through tpt1", TCTP and SIAH-1, 2002, pp.99, 14976~14981
12. Martincorena, I., "Somatic mutant clones colonize the human esophagus with age", Science, 362, pp.911~917 (2018)
13. Martincorena, I., "Tumor evolution. High burden and pervasive positive selection of somatic mutations in normal human skin", Science, 348, pp.880~886 (2015)
14. Kaufman, C. K., "A zebrafish melanoma model reveals emergence of neural crest identity during melanoma initiation", Science, 351, pp.aad2197~ (2016)
15. Lee, S., "Network inference analysis identifies SETDB1 as a key regulator for reverting colorectal cancer cells into differentiated normal-like cells", Mol. Cancer Res, 18, pp.118~129 (2020)
16. Brock, A., "Control of cancer formation by intrinsic genetic noise and microenvironmental cues", Nat. Rev. Cancer, 15, pp.499~509 (2015)
17. Powers, S., "Inducing stable reversion to achieve cancer control", Nat. Rev. Cancer, 16, pp.266~270 (2016)
18. Vogel, A., "Isolation and characterization of revertant cell lines. IV. Direct selection of serum-revertant sublines of SV40-transformed 3T3 mouse cells", J. Cell Physiol, 82, pp.189~198 (1973)
19. Proietti, S., "Tumor reversion and embryo morphogenetic factors", Semin. Cancer Biol, 79, pp.83~90 (2020)
20. Bizzarri, M., "Redifferentiation therapeutic strategies in cancer", Drug Discov. Today, 25, pp.731~738 (2020)
21. Bizzarri, M., "Tumor reversion : mesenchymal-epithelial transition as a critical step in managing the tumor-microenvironment cross-talk", Curr. Pharm. Des, 23, pp.4705~4715 (2017)
22. Takahashi, K., "Induction of pluripotent stem cells from mouse embryonic and adult fibroblast cultures by defined factors", Cell, 126, pp.663~676 (2006)
23. Ohnishi, K., "Premature termination of reprogramming in vivo leads to cancer development through altered epigenetic regulation", Cell, 156, pp.663~677 (2014)
24. Mizrachi, Y., "PC12 cells differentiate into chromaffin cell-like phenotype in coculture with adrenal medullary endothelial cells", Proc. Natl Acad. Sci. USA, 87, pp.6161~6165 (1990)
25. Arnold, J. T., "Effect of normal endometrial stroma on growth and differentiation in Ishikawa endometrial adenocarcinoma cells", Cancer Res, 62, pp.79~88 (2002)
26. Mulas, C., "Cell state transitions: definitions and challenges", Development, 148, pp.dev199950~ (2021)
27. Huang, S., "Encyclopedia of Complexity and Systems Science", pp.1180~1213 (2009), Springer
28. Huang, S., "Cell fates as high-dimensional attractor states of a complex gene regulatory network", Phys. Rev. Lett, 94, pp.128701~ (2005)
29. Waddington, C. H., "The Strategy of the Genes; a Discussion of Some Aspects of Theoretical Biology" (1957), Allen & Unwin
30. Huang, S., "Cancer attractors : a systems view of tumors from a gene network dynamics and developmental perspective", Semin. Cell Dev. Biol, 20, pp.869~876 (2009)
31. Choi, M., "Network dynamics-based cancer panel stratification for systemic prediction of anticancer drug response", Nat. Commun, 8, pp.1~12 (2017)
32. Choi, S. R., "Network analysis identifies regulators of basal-like breast cancer reprogramming and endocrine therapy vulnerability", Cancer Res, 82, pp.320~333 (2022)
33. Kim, Y., "Quantitative evaluation and reversion analysis of the attractor landscapes of an intracellular regulatory network for colorectal cancer", BMC Syst. Biol, 11, pp.45~ (2017)
34. Cho, S. H., "Attractor landscape analysis of colorectal tumorigenesis and its reversion", BMC Syst. Biol, 10, pp.96~ (2016)
35. Cho, K. H., "The reverse control of irreversible biological processes", WIRES Syst. Biol. Med, 8, pp.366~377 (2016)
36. Choi, M., "Attractor landscape analysis reveals feedback loops in the p53 network that control the cellular response to DNA damage", Sci. Signal, 5, pp.ra83~ (2012)
37. Shen-Orr, S. S., "Network motifs in the transcriptional regulation network of Escherichia coli", Nat. Genet, 31, pp.64~68 (2002)
38. Alon, U., "Network motifs : theory and experimental approaches", Nat. Rev. Genet, 8, pp.450~461 (2007)
39. Thomas, R., "Dynamical behaviour of biological regulatory networks—I. Biological role of feedback loops and practical use of the concept of the loop-characteristic state", Bull. Math. Biol, 57, pp.247~276 (1995)
40. Kaufman, M., "A new necessary condition on interaction graphs for multistationarity", J. Theor. Biol, 248, pp.675~685 (2007)
41. Kim, J. R., "Coupled feedback loops form dynamic motifs of cellular networks", Biophys. J, 94, pp.359~365 (2008)
42. Scheffer, M., "Anticipating critical transitions", Science, 338, pp.344~348 (2012)
43. Moris, N., "Transition states and cell fate decisions in epigenetic landscapes", Nat. Rev. Genet, 17, pp.693~703 (2016)
44. Mojtahedi, M., "Cell fate decision as high-dimensional critical state transition", PLoS Biol, 14, pp.e2000640~ (2016)
45. Poovathingal, S. K., "Critical points in tumorigenesis: a carcinogen-initiated phase transition analyzed via single-cell proteomics", Small, 12, pp.1425~1431 (2016)
46. Martincorena, I., "Universal patterns of selection in cancer and somatic tissues", Cell, 171, pp.1029~1041 (2017)
47. Tomasetti, C., "Only three driver gene mutations are required for the development of lung and colorectal cancers", Proc. Natl Acad. Sci. USA, 112, pp.118~123 (2015)
48. Shin, D., "Percolation transition of cooperative mutational effects in colorectal tumorigenesis", Nat. Commun, 8, pp.1270~ (2017)
49. Slotine, J.-J. E., "Applied Nonlinear Control. Vol. 199" (1991), Prentice hall
50. Fiedler, B., "Dynamics and control at feedback vertex sets. I: Informative and determining nodes in regulatory networks", J. Dyn. Differ. Equ, 25, pp.563~604 (2013)
51. Kim, J., "Discovery of a kernel for controlling biomolecular regulatory networks", Sci. Rep, 3, pp.2223~ (2013)
52. Zanudo, J. G., "Cell fate reprogramming by control of intracellular network dynamics", PLoS Comput. Biol, 11, pp.e1004193~ (2015)
53. Pina, C., "Inferring rules of lineage commitment in haematopoiesis", Nat. Cell Biol, 14, pp.287~294 (2012)
54. Nahta, R., "Evolving strategies for overcoming resistance to HER2-directed therapy : targeting the PI3K", Akt, Clin. Breast Cancer, pp.2010, 10[DOI]
55. Jaeger, S., "Quantification of pathway cross-talk reveals novel synergistic drug combinations for breast cancer", Cancer Res, 77, pp.459~469 (2017)
56. Klinger, B., "Network quantification of EGFR signaling unveils potential for targeted combination therapy", Mol. Syst. Biol, 9, pp.673~ (2013)
57. Prahallad, A., "Unresponsiveness of colon cancer to BRAF(V600E)inhibition through feedback activation of EGFR", Nature, 483, pp.100~103 (2012)
58. Nguyen, L. K., "Feedback regulation in cell signalling : lessons for cancer therapeutics", Semin. Cell Dev. Biol, 50, pp.85~94 (2016)
59. Paull, E. O., "A modular master regulator landscape controls cancer transcriptional identity", Cell, 184, pp.334~351 (2021)
60. Califano, A, "The recurrent architecture of tumour initiation, progression and drug sensitivity", Nat. Rev. Cancer, 17, pp.116~130 (2017)
61. Bennett, R. L., "Targeting Epigenetics in Cancer", Annu. Rev. Pharmacol. Toxicol, 58, pp.187~207 (2018)
62. Lambrechts, D., "Phenotype molding of stromal cells in the lung tumor microenvironment", Nat. Med, 24, pp.1277~1289 (2018)
63. Ding, J., "Cell lineage inference from SNP and scRNA-Seq data", Nucleic Acids Res, 47, pp.e56~ (2019)
64. Ding, J., "Reconstructing differentiation networks and their regulation from time series single-cell expression data", Genome Res, 28, pp.383~395 (2018)
65. Szklarczyk, D., "The STRING database in 2021 : customizable protein-protein networks, and functional characterization of user-uploaded gene", measurement sets, 2021, pp.49, D605~D612
66. Turei, D., "OmniPath : guidelines and gateway for literature-curated signaling pathway resources", Nat. Methods, 13, pp.966~967 (2016)
67. Cui, Q., "A map of human cancer signaling", Mol. Syst. Biol, 3, pp.152~ (2007)
68. Shin, S. -Y., "The switching role of β-adrenergic receptor signalling in cell survival or death decision of cardiomyocytes", Nat. Commun, 5, pp.5777~ (2014)
69. Sreenath, S. N., "Modelling the dynamics of signalling pathways", Essays Biochem, 45, pp.1~28 (2008)
70. Kohar, V., "Role of noise and parametric variation in the dynamics of gene regulatory circuits", NPJ Syst. Biol. Appl, 4, pp.40~ (2018)
71. Zhang, X., "A Monte Carlo method for in silico modeling and visualization of Waddington’s epigenetic landscape with intermediate details", Biosystems, 198, pp.104275~ (2020)
72. Daraselia, N., "Molecular signature and pathway analysis of human primary squamous and adenocarcinoma lung cancers", Am. J. Cancer Res, 2, pp.93~103 (2012)
73. Kim, D. S., "Association of FOSB exon 4 unmethylation with poor prognosis in patients with late‑stage non‑small cell lung cancer", Oncol. Rep, 43, pp.655~661 (2020)
74. Tang, H., "Upregulation of SPP1 is a marker for poor lung cancer prognosis and contributes to cancer progression and cisplatin resistance", Front. Cell Dev. Biol, 9, pp.646390~ (2021)
75. Yi, X., "SPP1 facilitates cell migration and invasion by targeting COL11A1 in lung adenocarcinoma", Cancer Cell Int, 22, pp.324~ (2022)
76. Todorov, H., "Network inference from singlecell transcriptomic data", Methods Mol. Biol, 1883, pp.235~249 (2019)
77. Nguyen, H., "A comprehensive survey of regulatory network inference methods using single cell RNA sequencing data", Brief. Bioinform, 22, pp.bbaa190~ (2021)
78. Rukhlenko, O. S., "Control of cell state transitions", Nature, 609, pp.975~985 (2022)

관련 논문AI추천